🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for Severe Hypertriglyceridemia

CS-121 APOC3 Base Editing in FCS NCT07176923EARLY Phase 11 site📍 Hefei CorrectSequence Therapeutics Co., Ltd · Tests: CS-121 A Study to Assess the Safety, Tolerability and Efficacy of ION775 NCT07604974Phase 217 sites📍 Lincoln📍 Aurora📍 Boca Raton Ionis Pharmaceuticals, Inc. · Tests: ION775 A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia NCT07269210Phase 241 sites📍 Phoenix📍 Tucson📍 Beverly Hills Eli Lilly and Company · Tests: Solbinsiran, Placebo Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis NCT06880770Phase 3140 sites📍 Los Angeles📍 Santa Clarita📍 New Haven Arrowhead Pharmaceuticals · Tests: Plozasiran, Placebo A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172Phase 117 sites📍 Hialeah📍 Jacksonville📍 Orlando CRISPR Therapeutics AG · Tests: CTX310 The LD Lync Study - Natural History Study of Lipodystrophy Syndromes NCT03087253n/a4 sites📍 Bethesda📍 Ann Arbor📍 Fortaleza University of Michigan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy